Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Operating Grant: Analyses of Existing Cohorts & Databases - IHDCYH

University of British Columbia

$74,443.00

Perinatal Use of Immunosuppressant Therapies and Risk of Infections in Mothers and Babies

EF 2016-17

Résumé
HEALTH PROBLEM: Autoimmune diseases - those that occur when the body attacks its own tissues - are more frequent among women than men and often strike during childbearing years. Because treatment with immunosuppressant drugs is needed to control disease activity, medication issues are common concerns regarding patients' childbearing and family decisions. An important issue is that information on the effects of these drugs and related risks of infections in the mother and her baby is scarce. RESEARCH SOLUTION: Taking advantage of the rich health data available in British Columbia, we created a pregnancy registry, which captures information on all births in the province between 2002 and 2012, with data on both mothers and babies. Using information on all drugs dispensed, we will identify women with autoimmune disease who used immunosuppressant drugs during pregnancy and compare them with women with autoimmune disease who did not use immunosuppressant drugs during pregnancy. This comparison will allow us to evaluate whether infections in mothers occur at higher rate among those who used immunosuppressant drugs during their pregnancy. This comparison will also allow us to evaluate whether infections in babies occur at higher rate among those whose mothers used immunosuppressant drugs during their pregnancy. IMPORTANCE: This will be the first study of infection risk with using immunosuppressant drugs during pregnancy, on both mothers and babies. Findings will help guide the care of these patients, thereby improving the lives of Canadian women suffering from autoimmune diseases.
Programme
Operating Grant: Analyses of Existing Cohorts & Databases - IHDCYH
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
363381
Name
De Vera Mary A
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Analyses of Existing Canadian Cohorts & Databases - Reproductive Maternal & Child Health
Projecttitle
Perinatal Use of Immunosuppressant Therapies and Risk of Infections in Mothers and Babies
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$74,443
Cihrequipment2
$0
Programname2
Operating Grant: Analyses of Existing Cohorts & Databases - IHDCYH
Keyworddelim
Autoimmune Diseases; Biologics; Disease Modifying Antirheumatic Drugs; Glucocorticosteroids; Immunosuppressant Therapies; Infections; Perinatal Pharmacoepidemiology; Pregnancy; Reproduction
Abstract
HEALTH PROBLEM: Autoimmune diseases - those that occur when the body attacks its own tissues - are more frequent among women than men and often strike during childbearing years. Because treatment with immunosuppressant drugs is needed to control disease activity, medication issues are common concerns regarding patients' childbearing and family decisions. An important issue is that information on the effects of these drugs and related risks of infections in the mother and her baby is scarce. RESEARCH SOLUTION: Taking advantage of the rich health data available in British Columbia, we created a pregnancy registry, which captures information on all births in the province between 2002 and 2012, with data on both mothers and babies. Using information on all drugs dispensed, we will identify women with autoimmune disease who used immunosuppressant drugs during pregnancy and compare them with women with autoimmune disease who did not use immunosuppressant drugs during pregnancy. This comparison will allow us to evaluate whether infections in mothers occur at higher rate among those who used immunosuppressant drugs during their pregnancy. This comparison will also allow us to evaluate whether infections in babies occur at higher rate among those whose mothers used immunosuppressant drugs during their pregnancy. IMPORTANCE: This will be the first study of infection risk with using immunosuppressant drugs during pregnancy, on both mothers and babies. Findings will help guide the care of these patients, thereby improving the lives of Canadian women suffering from autoimmune diseases.
Competitiondate
201609
Approvedterm2
1 yr 0 mth
Pinamesdelim
De Vera, Mary A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $74,443~ $0~